[1] Jeffery TK, Wanstall JC.Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension [J]. Pharmacol Ther, 2001, 92(1): 1-20.
[2] Mandegar M, Fung YC, Huang W, et al. Cellular and molecular mechanisms of pulmonary vascular remodeling: role in the development of pulmonary hypertension [J]. Microvasc Res, 2004, 68(2): 75-103.
[3] 田 真,蔡 鑫,唐碧双. 孔钾通道TASK1与缺氧性肺血管收缩的研究进展[J]. 国际心血管病杂志,2013,40(4): 236-239.
[4] Stenmark KR, Fagan KA, Frid MG.Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms [J]. Circ Res, 2006, 99(7): 675-691.
[5] Willis BC, duBois RM, Borok Z. Epithelial origin of myofibroblasts during fibrosis in the lung [J]. Proc Am Thorac Soc, 2006, 3(4): 377-382.
[6] 李 秀,刘 巍. 肌成纤维细胞在心肌梗死后重构中的作用及机制[J]. 国际心血管病杂志,2014,41(2): 88-90.
[7] De Gasparo M, Catt KJ, Inagami T, et al. The angiotensin Ⅱ receptors [J]. Pharmacol Rev, 2000, 52(3): 415-472.
[8] Filippatos G, Tilak M, Pinillos H, et al. Regulation of apoptosis by angiotensin Ⅱ in the heart and lungs [J]. Int J Mol Med, 2001, 7(3): 273-280.
[9] Sun Y, Ramires FJ, Weber KT. Fibrosis of atria and great vessels in response to angiotensin Ⅱ or aldosterone infusion [J]. Cardiovasc Res, 1997, 35(1): 138-147.
[10] 陶 婷,朱鼎良,龚兰生. 血管紧张素Ⅱ对血管外膜成纤维细胞Ⅰ型胶原合成及其mRNA表达的影响[J]. 中国病理生理杂志,2000,16(5): 405-408.